Adenovirus-mediated expression of PML suppresses growth and tumorigenicity of prostate cancer cells

Cancer Research

Volumn 57, Issue 10, 1997, Pages 1868-1872

  He, Dalin ^a   Mu, Zhao Mei ^a   Le, Xiaofeng ^a   Hsieh, Jer Tsong ^a,b   Pong, Rey Chen ^a,b   Chung, Leland W K ^a,c   Chang, Kun Sang ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA;

ADENOVIRUS; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER INHIBITION; CONTROLLED STUDY; GENE THERAPY; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; PROSTATE CANCER; VIRUS INFECTION; VIRUS RECOMBINANT;

ADENOVIRIDAE; ANIMALS; BLOTTING, WESTERN; CELL DIVISION; FLUORESCENT ANTIBODY TECHNIQUE; GENE THERAPY; HUMANS; MALE; MICE; MICE, NUDE; NEOPLASM PROTEINS; NUCLEAR PROTEINS; PROSTATIC NEOPLASMS; RECOMBINANT PROTEINS; TRANSCRIPTION FACTORS; TRANSFECTION; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS;

EID: 0031006321     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Parker, S. L., Tong, T., Bolden, S., and Wingo, P. A. Cancer statistics. CA Cancer J. Clin., 46: 5-27, 1996.
2. Kleinerman, D. I., Zhang W-W., Lin, S-H., Van, N. T., von Eschenbach, A. C., and Hsieh, J-T. Application of a tumor suppressor (C-CAM1)-expressing recombinant adenovirus in androgen-independent human prostate cancer therapy: a preclinical study. Cancer Res., 55: 2831-2836, 1995.
3. Levine, A. J. Tumor suppressor genes. Bioassays, 12: 60-66, 1990.
4. Chiao, P. J., Bischoff F. Z., Strong, L. C., Tainsky, M. A. The current state of oncogene and cancer: experimental approaches for analyzing oncogenetic events in human cancer. Cancer Metastasis Rev., 9: 63-80, 1990.
5. Weinberg, R. A. Tumor suppressor genes. Science (Washington DC), 254: 1138-1146, 1991.
6. Friedmann, T. Progress towards human gene therapy. Science (Washington DC), 244: 275-1281, 1989.
7. Friedmann, T. Gene therapy of cancer through restoration of tumor-suppressor functions? Cancer (Phila.), 70 (Suppl.): 1810-1817, 1992.
8. Zhang W-W., Fang, X., Mazur, W., French, B. A., Georges, R. N., and Roth, J. A. High-efficiency gene transfer and high-level expression of wild-type p53 in human lung cancer cells mediated by recombinant adenovirus. Cancer Gene Ther., 1: 5-13, 1994.
9. Srivastava, S., Katayose, D., Tong, Y. A., Craig, C. R., Mcleod, D. G., Moul, J. W., Cowan, K. H., and Seth, P. Recombinant adenovirus vector expressing wild-type p53 is a potent inhibitor of prostate cancer cell proliferation. Urology, 46: 843-848, 1995.
10. Yang, C., Cirielli, C., Capogrossi, M. C., and Passaniti, A. Adenovirus-mediated wild-type p53 expression induces apoptosis and suppresses tumorigenesis of prostatic tumor cells. Cancer Res., 55: 4210-4213, 1995.
11. Mu, Z-M., Chin, K-V., Liu, J-H., Lozano, G., and Chang, K-S. PML, a growth suppressor disrupted in acute promyelocytic leukemia. Mol. Cell. Biol., 14: 6859-6867, 1994.
12. Liu, J-H., Mu, Z-M., and Chang, K. S. PML suppresses oncogenic transformation of HIH/3T3 cells by activated neu. J. Exp. Med., 181: 1965-1973, 1995.
13. Koken, M. H. M., Cruz, G. L., Quignon, F., Viron, A., Alix, M. K. C., Thepot, J. S., Juhlin, L., Degos, L., Calvo, F., and de The, H. The PML growth-suppressor has an altered expression in human oncogenesis. Oncogene, 10: 1315-1324, 1995.
14. Terris, B., Baldin, V., Dubois, S., Degott, C., Flejou, J. F., Henin, D., and Dejean, A. PML nuclear bodies are general targets for inflammation and cell proliferation. Cancer Res., 55: 1590-1597, 1995.
15. Graham, F., and Prevec, L. Manipulation of adenovirus vector. In: E. J. Murray (ed.), Methods in Molecular Biology: Gene Transfer and Expression Protocol, Vol. 7, pp. 109-128. Clifton, NJ: Humana Press, 1991.
16. Zhang, W-W., Fang, X., Branch, C. D., Mazur, W., French, B. A., and Roth, J. A. Generation and identification of recombinant adenovirus by liposome-mediated transfection and PCR analysis. Biotechniques, 15: 868-872, 1993.
17. Le, X. F., Yang, P., and Chang, K. S. Analysis of the growth and transformation suppressor domains of PML. J. Biol. Chem., 271: 130-135, 1996.
18. Kanamaru, H., and Yoshida, O. Assessment of in vitro lymphokine activated killer (LAK) cell activity against renal cancer cell lines and its suppression by serum factor using crystal violet assay. Urol. Res., 17: 259-264, 1989.
19. Sokol, D. L., and Gewirtz, A. M. Gene therapy: basic concepts and recent advances. Crit. Rev. Eukaryotic Gene Expr., 6: 29-57, 1996.
20. Stratford-Perricaudet, L., and Perricaudet, M. Gene transfer into animals: the promise of adenovirus. In: O. Cohen-Haguenauer and M. Borion (eds.), Human Gene Transfer, Vol. 219, pp. 51-61. France: John Libbey Eurotext, 1991.
21. Taneja, S. S., Belldegrum, A., de Kernion, J. B., and Pang, S. Adenoviral vector mediated high efficiency gene transfer in prostate cancer cell lines. J. Urol., 151: 253A, 1994.
22. Ko, S-C., Gotoh, A., Thalmann G. N., Zhau H. E., Johnston D. A., Zhang W. W., Kao, C., and Chung, L. W. K. Molecular therapy with recombinant p53 adenovirus in an androgen-independent, metastatic human prostate cancer model. Hum. Gene Ther., 7: 1683-1691, 1996.
23. Oren, M., Maltzman, W., and Levine, A. J. Posttranslational regulation of the 54K cellular tumor antigen in normal and transformed cells. Mol. Cell. Biol., 1: 101-110, 1981.
24. Fujiwara, T., Gromm, E. A., Mukhopadhyay, T., Zhang, W-W., Owen-Schaub, L. B., and Roth, J. A. Induction of chemosensitivity in human lung cancer cells in vivo by adenovirus-mediated transfer of wild-type p53 gene. Cancer Res., 54: 2287-2291, 1994.
25. Liu, T-J., Zhang, W-W., Taylor, D. L., Roth, J. A., Goepfert, H., and Clayman, G. L. Growth suppression of human head and neck cancer cells by the introduction of a wild-type p53 gene via a recombinant adenovirus. Cancer Res., 54: 3662-3667, 1994.
26. Stadler, M., Chelbi-Alix, M. K., Koken, M. H. M., Venturini, L., Lee, C., Saib, A., Quignon, F., Pelicano, L., Guillemin, M-C., Schindler, C., and de The, H. Transcriptional induction of the PML growth suppressor gene by interferons is mediated through an ISRE and aGAS element. Oncogene, 11: 2565-2573, 1995.
27. Janek, P., Bruabd, P., and Hartman, N. R. The effect of estrogen-progesterone treatment on cell proliferation kinetics of hormone-dependent GR mouse mammary tumors. Cancer Res., 3: 3698-3704, 1975.